11/05/2022
A message from our Chief Science & Safety Advisor, Dr. Cheng Ruan:
As a physician, the most important thing when looking at any wellness product is to view its effectiveness through a concise and direct lens.
Instead of assuming how a h**p supplement may be beneficial, we’ve gone straight to the source of scientific support, looking at how people physically and mentally respond to our formulations. In this way, we now have a direct measurement and evaluation of how well these supplements work.
It’s no secret. The h**p space is now very crowded. One of the primary purposes of these ongoing clinical trials is to find a differentiation between h**p extracts and oils based on facts rather than assumptions. With data on how people actually responded, it gives us standardized outcomes and helps to support PrimeMyBody’s reputation as a leader in the h**p industry.
This is such a groundbreaking study because very few data-based studies have been recorded using cannabinoids and EEG brain wave activities. More importantly, what we studied was the effects of the calculated cannabinoid and terpene formula PrimeMyBody created for FOCUS. What you can see very clearly in the data and what was picked up on the qEEG is that FOCUS improves specific biomarkers like attention, cognition, speed of processing, and reaction time.
The ability to study specific formulations on the effects of the brain is crucial to how the h**p industry should shift. I am proud that at PrimeMyBody our core value is to bring the most scientific basis of proof into the industry. Creating studies such as what was done for FOCUS will be the industry standard moving into a new era of healing.
Wishing you good health,
Dr. Cheng Ruan, MD
PMB Chief Science & Safety Advisor
